A randomized phase 3 trial of the immunogenicity and safety of coadministration of a live-attenuated tetravalent dengue vaccine (TAK-003) and an inactivated hepatitis a (HAV) virus vaccine in a dengue non-endemic country.
暂无分享,去创建一个
Vianney Tricou | D. Wallace | S. Mandarić | N. Folschweiller | E. Loeliger | P. Collini | M. Brose | Z. Mojares | M. Rauscher | I. Lefevre | Vianney Tricou | Mahadev Ramjee | Susannah Eyre